medical use

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

Clarifying the patentability of medical use inventions in China

By AWA | Posted on May 20, 2020

At the end of 2019, the new Coronavirus (2019-nCoV) emerged. It has gone on to infect millions of people worldwide and so far, claimed the lives of over a quarter of a million people. COVID-19 has disrupted the world economy like never before. At the same time, it has brought unprecedented global attention to disease...

Read more : Clarifying the patentability of medical use inventions in China

Filed under: Insights

Tags: china, CNIPA, EPO, Gilead, inventions, JPO, medical use, patents, Remdesivir

Recent contributors

Emily Chamberlain, Senior Associate and Patents, Stockholm, Sweden

Emily Chamberlain

Senior Associate, Patents

Niklas Mattsson, Partner and European Patent Attorney, Stockholm, Sweden

Niklas Mattsson

Partner, European Patent Attorney, Authorised Swedish Patent Attorney, UPC Representative

Ai-Leen Lim, Partner and Attorney at Law, Hong Kong SAR

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President

Julia Wang, Senior Associate and Attorney at Law, Beijing, China

Julia Wang

Senior Associate, Attorney at Law

Ylva Strandberg, Counsel and AU and NZ Patent Attorney, Stockholm, Sweden

Ylva Strandberg

Counsel, AU and NZ Patent Attorney

Hongyue Li, Senior Associate and China Patent Attorney, Beijing, China

Hongyue Li

Senior Associate, China Patent Attorney